Alzchem Group AG

Alzchem Group AG

ACT0.DE
Alzchem Group AGDE flagDeutsche Börse
156.30
EUR
-1.40
- -
1.58BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
- -
- -
- -
34.78
36.87
36.96
37.27
41.62
53.5
53.16
54.47
55.62
54.84
Basic EPS, GAAP
-0.04
-0.04
-0.14
-0.13
2
2.23
1.77
1.94
2.72
2.96
3.4
5.31
6.28
5.72
Free Cash Flow per Basic Share
- -
- -
-0.22
-0.16
0.57
3.41
0.22
1.95
4.24
-0.42
7.15
10.33
13.56
8.41
Dividend per Share
- -
- -
- -
- -
1.75
1.1
0.9
0.75
0.77
1
1.05
1.2
1.8
1.8
Book Value per Share
- -
- -
- -
- -
5.47
6.58
5.87
6.57
8.65
14.21
15.88
20.25
25.32
21.51
Tangible Book Value per Share
- -
- -
- -
- -
5.37
6.5
5.72
6.4
8.42
13.92
15.52
19.89
24.97
21.15
Basic Weighted Avg Shares
- -
- -
- -
- -
10
10
10
10
10
10
10
10
10
10
Sales/Revenue/Turnover
- -
- -
- -
- -
354
375
376
379
422
542
541
554
562
556
Operating Margin (%)
- -
- -
- -
- -
9.49
10.53
7.93
8.53
8.82
5.6
10.53
14.1
16.54
15.17
Depreciation Expense
- -
- -
- -
- -
14
15
19
23
24
26
26
26
27
26
Net Income, GAAP
- -
- -
- -
- -
20
23
18
20
28
30
35
54
63
58
Effective Tax Rate (%)
- -
- -
- -
- -
29.87
28.62
28.81
26.96
23.96
26.79
27.8
28
27.64
27.82
Profit Margin (%)
- -
- -
- -
- -
5.76
6.03
4.78
5.19
6.53
5.54
6.4
9.76
11.29
10.43
Working Capital
- -
- -
- -
- -
62
61
70
73
76
83
134
156
178
194
LT Debt
- -
- -
- -
- -
19
33
58
55
43
32
52
43
36
40
Total Equity
- -
- -
- -
- -
58
68
61
69
90
146
164
207
258
219
Return on Invested Capital (%)
- -
- -
- -
- -
44.59
23.68
15.61
16.69
19.05
10.9
16.59
21.6
22.49
23.01
Return on Capital (%)
- -
- -
- -
- -
44.88
21.62
16.64
16.47
20.3
16.4
16.93
23.89
23.8
24.34
Return on Common Equity (%)
-251.36
- -
- -
- -
73.26
36.93
28.37
31.1
35.71
25.95
22.65
29.46
27.48
29.12

Capital Structure

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
ST Debt
9
- -
8
LT Borrowings
41
- -
38
LT Finance Leases
2
- -
2
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
10
10
10
Market Capitalization
- -
- -
- -

Working Capital

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
Total Current Assets
262
320
299
Cash, Cash Equivalents & STI
63
91
64
Accounts Receivable, Net
79
85
88
Inventories
100
112
117
Total Current Liabilities
105
118
105
Payables & Accruals
- -
- -
- -
ST Debt
9
- -
8
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
31.36%
24.47%
Free Cash Flow
-1,670.85%
-346.48%
30.31%
Net Income, GAAP
-7,089.59%
27.55%
17.35%
Sales/Revenue/Turnover
- -
8.68%
1.42%
Total Cash Common Dividend
- -
20.15%
48.95%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
150
136
129
139
554
2025
145
143
137
- -
562
2026
149
155
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1.2
1.41
1.22
- -
5.31
2025
1.44
1.57
- -
- -
6.28
2026
1.77
1.66
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
1.2
- -
- -
1.2
2025
- -
1.8
- -
- -
1.8
2026
- -
2.1
- -
- -
- -

Company Description

CEO
Andreas Niedermaier
Full Time Employees
1,765
Sector
Basic Materials
Industry
Chemicals
Address
Dr.-Albert-Frank-Strasse 32 Trostberg BV Germany 83308
IPO Date
Sep 9, 2026
Business
Alzchem Group AG is a globally active specialty chemicals company that develops, produces and markets products based on the calcium carbide and calcium cyanamide value chain, with operations organized across Specialty Chemicals, Basics & Intermediates, and Other & Holding segments. Founded in 1908 and headquartered in Trostberg, Germany, the company serves customers in nutrition, agriculture, fine chemicals, renewable energy, metallurgy and industrial applications. Its core portfolio includes dietary supplements and ingredients such as Creapure and Creavitalis; specialty feed and food ingredients; epoxy curing agents under the DYHARD brand; silicon nitride under the SILZOT brand for advanced ceramics and solar wafers; technical gases; fertilizer and agrochemical products, including germicides, plant growth regulators and plant protection additives; as well as other chemical intermediates and carbide-based products. Alzchem operates primarily in Europe and also serves international markets through its sales and production network, with the group’s parent company and key operating subsidiaries located in Trostberg, Germany. In recent periods, the company has accelerated its strategic shift toward higher-value specialty chemicals and ingredients, including record sales and EBITDA in fiscal 2025, a planned increase in the dividend, and continued expansion of its creatine business. Alzchem and Ehrmann launched a cooperation in 2025 to expand high-protein products using Creavitalis, while the company also advanced capacity expansions for guanidine nitrate and nitroguanidine in Germany and continued site selection for a new nitroguanidine plant in the United States. In addition, Alzchem approved a new investment program of around EUR 120 million for a largely automated creatine production plant and related infrastructure, with gradual commissioning planned from the second half of 2027, underscoring its focus on profitable growth and capacity expansion.